Patents by Inventor Basak Ozaslan

Basak Ozaslan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240058533
    Abstract: An insulin device configured to control insulin dispensing based on insulin sensitivity. The insulin device includes a processor configured to receive insulin dosing schedule information, psychological stress level data, and body mass index (BMI) data; a sensor configured to generate a blood glucose level measurement. The sensor is calibrated as a function of the psychological stress level data and the BMI data and the processor is configured to monitor and detect changes of the blood glucose level measurement that are determined to have occurred as a function of changes of the psychological stress level data, and identify a time when the BMI data counteracts a detected change in the blood glucose level measurement. The insulin device also includes an insulin dispensing valve controlled by the processor to change the insulin dosing schedule information in accordance with the counteracting BMI data.
    Type: Application
    Filed: October 26, 2023
    Publication date: February 22, 2024
    Applicant: UNIVERSITY OF VIRGINIA PATENT FOUNDATION
    Inventors: Stephen D. PATEK, Basak OZASLAN, Linda GONDER-FREDERICK
  • Patent number: 11839745
    Abstract: An insulin device configured to control insulin dispensing based on insulin sensitivity. The insulin device includes a processor configured to receive insulin dosing schedule information, psychological stress level data, and body mass index (BMI) data; a sensor configured to generate a blood glucose level measurement. The sensor is calibrated as a function of the psychological stress level data and the BMI data and the processor is configured to monitor and detect changes of the blood glucose level measurement that are determined to have occurred as a function of changes of the psychological stress level data, and identify a time when the BMI data counteracts a detected change in the blood glucose level measurement. The insulin device also includes an insulin dispensing valve controlled by the processor to change the insulin dosing schedule information in accordance with the counteracting BMI data.
    Type: Grant
    Filed: July 13, 2021
    Date of Patent: December 12, 2023
    Assignee: UNIVERSITY OF VIRGINIA PATENT FOUNDATION
    Inventors: Stephen D. Patek, Basak Ozaslan, Linda Gonder-Frederick
  • Publication number: 20210346602
    Abstract: An insulin device configured to control insulin dispensing based on insulin sensitivity. The insulin device includes a processor configured to receive insulin dosing schedule information, psychological stress level data, and body mass index (BMI) data; a sensor configured to generate a blood glucose level measurement. The sensor is calibrated as a function of the psychological stress level data and the BMI data and the processor is configured to monitor and detect changes of the blood glucose level measurement that are determined to have occurred as a function of changes of the psychological stress level data, and identify a time when the BMI data counteracts a detected change in the blood glucose level measurement. The insulin device also includes an insulin dispensing valve controlled by the processor to change the insulin dosing schedule information in accordance with the counteracting BMI data.
    Type: Application
    Filed: July 13, 2021
    Publication date: November 11, 2021
    Applicant: UNIVERSITY OF VIRGINIA PATENT FOUNDATION
    Inventors: Stephen D. PATEK, Basak OZASLAN, Linda GONDER-FREDERICK
  • Patent number: 11090433
    Abstract: An insulin device configured to control insulin dispensing based on insulin sensitivity. The insulin device includes a processor configured to receive insulin dosing schedule information, psychological stress level data, and body mass index (BMI) data; a sensor configured to generate a blood glucose level measurement. The sensor is calibrated as a function of the psychological stress level data and the BMI data and the processor is configured to monitor and detect changes of the blood glucose level measurement that are determined to have occurred as a function of changes of the psychological stress level data, and identify a time when the BMI data counteracts a detected change in the blood glucose level measurement. The insulin device also includes an insulin dispensing valve controlled by the processor to change the insulin dosing schedule information in accordance with the counteracting BMI data.
    Type: Grant
    Filed: February 15, 2018
    Date of Patent: August 17, 2021
    Assignee: UNIVERSITY O VIRGINIA PATENT FOUNDATION
    Inventors: Stephen D. Patek, Basak Ozaslan, Linda Gonder-Frederick
  • Publication number: 20200230319
    Abstract: An insulin device configured to control insulin dispensing based on insulin sensitivity. The insulin device includes a processor configured to receive insulin dosing schedule information, psychological stress level data, and body mass index (BMI) data; a sensor configured to generate a blood glucose level measurement. The sensor is calibrated as a function of the psychological stress level data and the BMI data and the processor is configured to monitor and detect changes of the blood glucose level measurement that are determined to have occurred as a function of changes of the psychological stress level data, and identify a time when the BMI data counteracts a detected change in the blood glucose level measurement. The insulin device also includes an insulin dispensing valve controlled by the processor to change the insulin dosing schedule information in accordance with the counteracting BMI data.
    Type: Application
    Filed: February 15, 2018
    Publication date: July 23, 2020
    Applicant: University of Virginia Patent Foundation
    Inventors: Stephen D. PATEK, Basak OZASLAN, Linda GONDER-FREDERICK
  • Publication number: 20190252055
    Abstract: A computer-implemented method for treating a patient suffering from T1D. The method can include quantifying physical activity (PA) of the patient; calculating an accumulated PA periodically based on the quantified PA, the accumulated PA indicating an aggregate of the PA; and generating an activity informed insulin bolus by adjusting a prevalent functional insulin therapy bolus with a previous activity component, wherein the previous activity component is based on the accumulated daily PA, an activity profile, and an activity factor of the patient. The method can include determining an additional glucose uptake within a time period, the additional glucose uptake being caused by a PA; translating the additional glucose uptake into a number of insulin units with a same BG lowering impact; and generating an activity informed insulin bolus by adjusting a prevalent functional insulin therapy bolus with the insulin units.
    Type: Application
    Filed: February 13, 2019
    Publication date: August 15, 2019
    Applicant: The University of Virginia Licensing and Ventures Group
    Inventors: Marc D. BRETON, Stephen D. PATEK, Basak Ozaslan